Infibeam Avenues Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 8, 2025, 1:45 pm

Market Cap	5,419 Cr.
Current Price	19.4
High / Low	40.1/17.3
Stock P/E	24.1
Book Value	12.9
Dividend Yield	0.26 %
ROCE	6.27 %
ROE	4.71 %
Face Value	1.00
PEG Ratio	0.98

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Infibeam Avenues Ltd

Competitors of Infibeam Avenues Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
AGS Transact Technologies Ltd	171 Cr.	13.4	118/13.4		41.8	0.00 %	1.26 %	16.3 %	10.0
Infibeam Avenues Ltd	5,419 Cr.	19.4	40.1/17.3	24.1	12.9	0.26 %	6.27 %	4.71 %	1.00
DigiSpice Technologies Ltd	523 Cr.	22.4	52.8/18.0	71.2	10.4	0.00 %	10.7 %	3.74 %	3.00
Industry Average	2,037.67 Cr	18.40		47.65	21.70	0.09%	6.08%	8.25%	4.67

All Competitor Stocks of Infibeam Avenues Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	397	369	418	477	415	653	742	787	907	727	745	1,017	1,070
Expenses	359	327	377	438	367	606	694	717	842	662	676	939	992
Operating Profit	38	42	41	39	48	47	49	70	65	65	69	78	78
OPM %	10%	11%	10%	8%	11%	7%	7%	9%	7%	9%	9%	8%	7%
Other Income	6	3	4	33	13	21	3	2	6	16	32	4	27
Interest	0	0	0	1	0	1	1	1	0	1	1	2	2
Depreciation	13	16	15	15	16	16	16	17	17	18	16	17	19
Profit before tax	30	28	30	56	45	51	35	55	54	62	83	62	84
Tax %	20%	0%	24%	29%	21%	25%	28%	27%	21%	21%	17%	24%	24%
Net Profit	24	28	23	40	35	38	25	41	43	49	69	47	64
EPS in Rs	0.09	0.11	0.09	0.15	0.13	0.15	0.10	0.15	0.16	0.18	0.25	0.16	0.22

Last Updated: February 28, 2025, 7:15 pm

Below is a detailed analysis of the quarterly data for Infibeam Avenues Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is ₹1,070.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,017.00 Cr. (Sep 2024) to ₹1,070.00 Cr., marking an increase of ₹53.00 Cr..
For Expenses, as of Dec 2024, the value is ₹992.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 939.00 Cr. (Sep 2024) to ₹992.00 Cr., marking an increase of ₹53.00 Cr..
For Operating Profit, as of Dec 2024, the value is ₹78.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 78.00 Cr..
For OPM %, as of Dec 2024, the value is 7.00%. The value appears to be declining and may need further review. It has decreased from 8.00% (Sep 2024) to 7.00%, marking a decrease of 1.00%.
For Other Income, as of Dec 2024, the value is ₹27.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Sep 2024) to ₹27.00 Cr., marking an increase of ₹23.00 Cr..
For Interest, as of Dec 2024, the value is ₹2.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 2.00 Cr..
For Depreciation, as of Dec 2024, the value is ₹19.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.00 Cr. (Sep 2024) to ₹19.00 Cr., marking an increase of ₹2.00 Cr..
For Profit before tax, as of Dec 2024, the value is ₹84.00 Cr.. The value appears strong and on an upward trend. It has increased from 62.00 Cr. (Sep 2024) to ₹84.00 Cr., marking an increase of ₹22.00 Cr..
For Tax %, as of Dec 2024, the value is 24.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 24.00%.
For Net Profit, as of Dec 2024, the value is ₹64.00 Cr.. The value appears strong and on an upward trend. It has increased from 47.00 Cr. (Sep 2024) to ₹64.00 Cr., marking an increase of ₹17.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 0.22. The value appears strong and on an upward trend. It has increased from ₹0.16 (Sep 2024) to 0.22, marking an increase of ₹0.06.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 3:55 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	151	207	288	337	441	839	1,159	633	676	1,294	1,962	3,171	3,559
Expenses	173	228	291	315	375	683	983	484	534	1,149	1,787	2,920	3,269
Operating Profit	-22	-20	-2	22	67	156	176	149	142	145	175	251	290
OPM %	-15%	-10%	-1%	7%	15%	19%	15%	23%	21%	11%	9%	8%	8%
Other Income	1	2	7	5	16	31	66	73	19	18	71	28	79
Interest	1	1	1	1	4	6	6	4	4	2	2	3	6
Depreciation	3	7	13	18	22	66	82	87	75	63	62	69	70
Profit before tax	-25	-27	-10	9	56	115	153	130	82	98	182	208	292
Tax %	0%	0%	-0%	-1%	23%	23%	18%	17%	14%	15%	25%	25%
Net Profit	-25	-26	-11	9	44	88	126	108	70	84	136	156	231
EPS in Rs	-0.16	-0.16	-0.06	0.04	0.20	0.41	0.48	0.41	0.27	0.32	0.52	0.57	0.81
Dividend Payout %	0%	0%	0%	0%	0%	3%	0%	6%	9%	15%	10%	9%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-4.00%	57.69%	181.82%	388.89%	100.00%	43.18%	-14.29%	-35.19%	20.00%	61.90%	14.71%
Change in YoY Net Profit Growth (%)	0.00%	61.69%	124.13%	207.07%	-288.89%	-56.82%	-57.47%	-20.90%	55.19%	41.90%	-47.20%

Infibeam Avenues Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

No data available for the compounded sales growth chart.

Balance Sheet

Last Updated: December 14, 2024, 3:25 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	38	40	43	53	54	54	66	66	133	268	268	278	278
Reserves	-14	43	170	610	729	2,572	2,671	2,737	2,755	2,690	2,898	3,179	3,324
Borrowings	43	9	5	6	136	67	40	26	20	7	8	83	136
Other Liabilities	53	44	50	81	124	275	396	300	642	889	930	1,675	1,506
Total Liabilities	119	135	268	750	1,043	2,968	3,174	3,130	3,550	3,854	4,104	5,216	5,245
Fixed Assets	25	45	51	67	90	2,115	2,102	2,126	2,101	2,080	2,143	2,130	2,460
CWIP	6	8	26	19	121	60	32	0	16	146	74	311	104
Investments	0	0	0	0	60	27	102	392	457	394	461	560	452
Other Assets	89	82	191	664	772	768	938	612	976	1,234	1,425	2,215	2,228
Total Assets	119	135	268	750	1,043	2,968	3,174	3,130	3,550	3,854	4,104	5,216	5,245

Below is a detailed analysis of the balance sheet data for Infibeam Avenues Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹278.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹278.00 Cr..
For Reserves, as of Sep 2024, the value is ₹3,324.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹3,179.00 Cr. (Mar 2024) to ₹3,324.00 Cr., marking an increase of 145.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹136.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹83.00 Cr. (Mar 2024) to ₹136.00 Cr., marking an increase of 53.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹1,506.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹1,675.00 Cr. (Mar 2024) to ₹1,506.00 Cr., marking a decrease of 169.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹5,245.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹5,216.00 Cr. (Mar 2024) to ₹5,245.00 Cr., marking an increase of 29.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹2,460.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹2,130.00 Cr. (Mar 2024) to ₹2,460.00 Cr., marking an increase of 330.00 Cr..
For CWIP, as of Sep 2024, the value is ₹104.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹311.00 Cr. (Mar 2024) to ₹104.00 Cr., marking a decrease of 207.00 Cr..
For Investments, as of Sep 2024, the value is ₹452.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹560.00 Cr. (Mar 2024) to ₹452.00 Cr., marking a decrease of 108.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹2,228.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹2,215.00 Cr. (Mar 2024) to ₹2,228.00 Cr., marking an increase of 13.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹5,245.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹5,216.00 Cr. (Mar 2024) to ₹5,245.00 Cr., marking an increase of 29.00 Cr..

Notably, the Reserves (₹3,324.00 Cr.) exceed the Borrowings (136.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	-11	-11	-21	24	59	97	308	22	155	122	113	720
Cash from Investing Activity +	-17	-17	-91	-3	-558	20	-280	-42	-55	-55	-88	-460
Cash from Financing Activity +	28	30	123	440	162	-97	-54	-26	-9	-36	37	178
Net Cash Flow	1	2	11	461	-338	20	-27	-45	91	31	61	437

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-65.00	-29.00	-7.00	16.00	-69.00	89.00	136.00	123.00	122.00	138.00	167.00	168.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	86	30	42	52	46	48	8	31	39	23	12	15
Inventory Days	14	19	20	37	13	15	-0
Days Payable	104	54	50	43	23	32
Cash Conversion Cycle	-3	-5	12	46	36	31	8	31	39	23	12	15
Working Capital Days	-8	-16	15	25	171	62	101	84	56	23	30	-14
ROCE %	-35%	-33%	-5%	2%	8%	7%	4%	4%	3%	3%	6%	6%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	30.64%	30.64%	30.64%	30.64%	30.63%	30.63%	29.13%	28.13%	27.43%	27.43%	27.43%	27.36%
FIIs	7.01%	7.08%	7.07%	6.00%	6.46%	6.11%	6.30%	6.31%	7.51%	6.57%	6.80%	7.17%
DIIs	0.04%	0.04%	0.05%	0.06%	0.07%	0.07%	0.08%	0.10%	0.08%	0.09%	0.12%	0.15%
Public	61.89%	61.78%	61.78%	62.86%	62.38%	62.74%	64.03%	65.02%	64.56%	65.48%	65.21%	64.89%
Others	0.42%	0.46%	0.46%	0.46%	0.46%	0.46%	0.46%	0.44%	0.44%	0.44%	0.44%	0.44%
No. of Shareholders	2,12,793	2,23,335	2,31,277	2,40,992	2,41,947	2,79,607	4,66,698	5,06,308	8,87,893	8,37,198	8,29,167	7,95,632

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Nippon India Nifty Smallcap 250 Index Fund	1,027,174	0.34	3.61	521,693	2025-03-11	96.89%
Motilal Oswal Nifty Smallcap 250 Index Fund	627,395	0.33	2.2	521,693	2025-03-11	20.26%
SBI Nifty Smallcap 250 Index Fund	521,693	0.33	1.83	521,693	2025-03-11	0%
ICICI Prudential Nifty Smallcap 250 Index Fund	238,200	0.33	0.84	521,693	2025-03-11	-54.34%
Motilal Oswal Nifty 500 Index Fund	62,231	0.03	0.22	521,693	2025-03-11	-88.07%
Edelweiss Nifty Smallcap 250 Index Fund	28,525	0.33	0.1	521,693	2025-03-11	-94.53%
ICICI Prudential S&P BSE 500 ETF	16,107	0.03	0.06	521,693	2025-03-11	-96.91%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	1.00	1.00	1.00	1.00	1.00
Basic EPS (Rs.)	0.57	0.51	0.32	0.53	1.63
Diluted EPS (Rs.)	0.56	0.50	0.31	0.52	1.63
Cash EPS (Rs.)	0.81	0.75	0.51	1.03	2.15
Book Value[Excl.RevalReserv]/Share (Rs.)	12.42	11.82	11.04	21.70	42.15
Book Value[Incl.RevalReserv]/Share (Rs.)	12.42	11.82	11.04	21.70	42.15
Revenue From Operations / Share (Rs.)	11.40	7.33	4.83	5.08	9.52
PBDIT / Share (Rs.)	1.01	0.93	0.57	1.14	2.45
PBIT / Share (Rs.)	0.76	0.70	0.34	0.57	1.14
PBT / Share (Rs.)	0.75	0.69	0.33	0.54	1.20
Net Profit / Share (Rs.)	0.56	0.52	0.28	0.46	0.83
NP After MI And SOA / Share (Rs.)	0.56	0.52	0.32	0.54	1.62
PBDIT Margin (%)	8.85	12.75	11.97	22.46	25.73
PBIT Margin (%)	6.68	9.61	7.13	11.36	11.93
PBT Margin (%)	6.60	9.51	6.98	10.82	12.56
Net Profit Margin (%)	4.98	7.17	5.85	9.11	8.73
NP After MI And SOA Margin (%)	4.98	7.11	6.68	10.69	17.06
Return on Networth / Equity (%)	4.57	4.40	2.92	2.50	3.85
Return on Capital Employeed (%)	5.68	5.68	3.00	2.61	2.64
Return On Assets (%)	3.03	3.40	2.24	2.03	3.45
Long Term Debt / Equity (X)	0.02	0.00	0.00	0.00	0.01
Total Debt / Equity (X)	0.02	0.00	0.00	0.01	0.01
Asset Turnover Ratio (%)	0.68	0.49	0.32	0.18	0.19
Current Ratio (X)	1.39	1.60	1.37	1.45	1.86
Quick Ratio (X)	1.39	1.60	1.37	1.45	1.86
Dividend Payout Ratio (NP) (%)	8.44	0.00	15.33	0.00	7.35
Dividend Payout Ratio (CP) (%)	5.88	0.00	8.89	0.00	4.06
Earning Retention Ratio (%)	91.56	0.00	84.67	0.00	92.65
Cash Earning Retention Ratio (%)	94.12	0.00	91.11	0.00	95.94
Interest Coverage Ratio (X)	118.41	128.83	80.14	41.54	38.38
Interest Coverage Ratio (Post Tax) (X)	67.63	73.48	40.14	17.86	12.70
Enterprise Value (Cr.)	8854.22	3522.96	4966.30	6150.57	2185.77
EV / Net Operating Revenue (X)	2.79	1.80	3.84	9.10	3.45
EV / EBITDA (X)	31.54	14.07	32.04	40.50	13.42
MarketCap / Net Operating Revenue (X)	2.99	1.93	4.00	9.33	3.57
Retention Ratios (%)	91.55	0.00	84.66	0.00	92.64
Price / BV (X)	2.75	1.20	1.75	2.18	0.80
Price / Net Operating Revenue (X)	2.99	1.93	4.00	9.33	3.57
EarningsYield	0.01	0.03	0.01	0.01	0.04

After reviewing the key financial ratios for Infibeam Avenues Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
For Basic EPS (Rs.), as of Mar 24, the value is 0.57. This value is below the healthy minimum of 5. It has increased from 0.51 (Mar 23) to 0.57, marking an increase of 0.06.
For Diluted EPS (Rs.), as of Mar 24, the value is 0.56. This value is below the healthy minimum of 5. It has increased from 0.50 (Mar 23) to 0.56, marking an increase of 0.06.
For Cash EPS (Rs.), as of Mar 24, the value is 0.81. This value is below the healthy minimum of 3. It has increased from 0.75 (Mar 23) to 0.81, marking an increase of 0.06.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 12.42. It has increased from 11.82 (Mar 23) to 12.42, marking an increase of 0.60.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 12.42. It has increased from 11.82 (Mar 23) to 12.42, marking an increase of 0.60.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 11.40. It has increased from 7.33 (Mar 23) to 11.40, marking an increase of 4.07.
For PBDIT / Share (Rs.), as of Mar 24, the value is 1.01. This value is below the healthy minimum of 2. It has increased from 0.93 (Mar 23) to 1.01, marking an increase of 0.08.
For PBIT / Share (Rs.), as of Mar 24, the value is 0.76. This value is within the healthy range. It has increased from 0.70 (Mar 23) to 0.76, marking an increase of 0.06.
For PBT / Share (Rs.), as of Mar 24, the value is 0.75. This value is within the healthy range. It has increased from 0.69 (Mar 23) to 0.75, marking an increase of 0.06.
For Net Profit / Share (Rs.), as of Mar 24, the value is 0.56. This value is below the healthy minimum of 2. It has increased from 0.52 (Mar 23) to 0.56, marking an increase of 0.04.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 0.56. This value is below the healthy minimum of 2. It has increased from 0.52 (Mar 23) to 0.56, marking an increase of 0.04.
For PBDIT Margin (%), as of Mar 24, the value is 8.85. This value is below the healthy minimum of 10. It has decreased from 12.75 (Mar 23) to 8.85, marking a decrease of 3.90.
For PBIT Margin (%), as of Mar 24, the value is 6.68. This value is below the healthy minimum of 10. It has decreased from 9.61 (Mar 23) to 6.68, marking a decrease of 2.93.
For PBT Margin (%), as of Mar 24, the value is 6.60. This value is below the healthy minimum of 10. It has decreased from 9.51 (Mar 23) to 6.60, marking a decrease of 2.91.
For Net Profit Margin (%), as of Mar 24, the value is 4.98. This value is below the healthy minimum of 5. It has decreased from 7.17 (Mar 23) to 4.98, marking a decrease of 2.19.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 4.98. This value is below the healthy minimum of 8. It has decreased from 7.11 (Mar 23) to 4.98, marking a decrease of 2.13.
For Return on Networth / Equity (%), as of Mar 24, the value is 4.57. This value is below the healthy minimum of 15. It has increased from 4.40 (Mar 23) to 4.57, marking an increase of 0.17.
For Return on Capital Employeed (%), as of Mar 24, the value is 5.68. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 23) which recorded 5.68.
For Return On Assets (%), as of Mar 24, the value is 3.03. This value is below the healthy minimum of 5. It has decreased from 3.40 (Mar 23) to 3.03, marking a decrease of 0.37.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.02. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 23) to 0.02, marking an increase of 0.02.
For Total Debt / Equity (X), as of Mar 24, the value is 0.02. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 0.02, marking an increase of 0.02.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.68. It has increased from 0.49 (Mar 23) to 0.68, marking an increase of 0.19.
For Current Ratio (X), as of Mar 24, the value is 1.39. This value is below the healthy minimum of 1.5. It has decreased from 1.60 (Mar 23) to 1.39, marking a decrease of 0.21.
For Quick Ratio (X), as of Mar 24, the value is 1.39. This value is within the healthy range. It has decreased from 1.60 (Mar 23) to 1.39, marking a decrease of 0.21.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 8.44. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 8.44, marking an increase of 8.44.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 5.88. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 5.88, marking an increase of 5.88.
For Earning Retention Ratio (%), as of Mar 24, the value is 91.56. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 91.56, marking an increase of 91.56.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 94.12. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 94.12, marking an increase of 94.12.
For Interest Coverage Ratio (X), as of Mar 24, the value is 118.41. This value is within the healthy range. It has decreased from 128.83 (Mar 23) to 118.41, marking a decrease of 10.42.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 67.63. This value is within the healthy range. It has decreased from 73.48 (Mar 23) to 67.63, marking a decrease of 5.85.
For Enterprise Value (Cr.), as of Mar 24, the value is 8,854.22. It has increased from 3,522.96 (Mar 23) to 8,854.22, marking an increase of 5,331.26.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.79. This value is within the healthy range. It has increased from 1.80 (Mar 23) to 2.79, marking an increase of 0.99.
For EV / EBITDA (X), as of Mar 24, the value is 31.54. This value exceeds the healthy maximum of 15. It has increased from 14.07 (Mar 23) to 31.54, marking an increase of 17.47.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.99. This value is within the healthy range. It has increased from 1.93 (Mar 23) to 2.99, marking an increase of 1.06.
For Retention Ratios (%), as of Mar 24, the value is 91.55. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 91.55, marking an increase of 91.55.
For Price / BV (X), as of Mar 24, the value is 2.75. This value is within the healthy range. It has increased from 1.20 (Mar 23) to 2.75, marking an increase of 1.55.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.99. This value is within the healthy range. It has increased from 1.93 (Mar 23) to 2.99, marking an increase of 1.06.
For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 23) to 0.01, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Infibeam Avenues Ltd as of March 12, 2025 is: ₹11.74

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, Infibeam Avenues Ltd is Overvalued by 39.48% compared to the current share price 19.40

Intrinsic Value of Infibeam Avenues Ltd as of March 12, 2025 is: 14.62

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, Infibeam Avenues Ltd is Overvalued by 24.64% compared to the current share price 19.40

Last 5 Year EPS CAGR: 24.57%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock is trading at a low valuation with an average P/B ratio of 0.70 and average Dividend Yield of 9.34%. The company has higher reserves (1,874.15 cr) compared to borrowings (45.08 cr), indicating strong financial stability. The company has shown consistent growth in sales (275.46 cr) and profit (97.15 cr) over the years.	The stock has a low average ROCE of -2.50%, which may not be favorable. The stock has a high average Working Capital Days of 44.08, which may not be favorable. The stock has a high average Cash Conversion Cycle of 20.42, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Infibeam Avenues Ltd:
1. Net Profit Margin: 4.98%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 5.68% (Industry Average ROCE: 6.08%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 4.57% (Industry Average ROE: 8.25%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 67.63
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.39
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 24.1 (Industry average Stock P/E: 47.65)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.02
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Infibeam Avenues Ltd. is a Public Limited Listed company incorporated on 30/06/2010 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L64203GJ2010PLC061366 and registration number is 061366. Currently Company is involved in the business activities of Providing software support and maintenance to the clients. Company's Total Operating Revenue is Rs. 2963.21 Cr. and Equity Capital is Rs. 278.20 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Financial Technologies (Fintech)	28th Floor, GIFT Two Building, Gandhinagar District Gujarat 382355	ir@ia.ooo http://www.ia.ooo

Management
Name	Position Held
Mr. Ajit Mehta	Chairman Emeritus
Mr. Vishal Mehta	Chairman & Managing Director
Mr. Vishwas Patel	Joint Managing Director
Mr. Keyoor Bakshi	Independent Director
Mr. Roopkishan Dave	Independent Director
Ms. Vijaylaxmi Sheth	Independent Director
Mr. Piyushkumar Sinha	Independent Director
Mr. Narayanan Sadanandan	Independent Director

FAQ

What is the latest intrinsic value of Infibeam Avenues Ltd?

The latest intrinsic value of Infibeam Avenues Ltd as on 11 March 2025 is ₹11.74, which is 39.48% lower than the current market price of 19.40, indicating the stock is overvalued by 39.48%. The intrinsic value of Infibeam Avenues Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹5,419 Cr. and recorded a high/low of ₹40.1/17.3 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹3,324 Cr and total liabilities of ₹5,245 Cr.

What is the Market Cap of Infibeam Avenues Ltd?

The Market Cap of Infibeam Avenues Ltd is 5,419 Cr..

What is the current Stock Price of Infibeam Avenues Ltd as on 11 March 2025?

The current stock price of Infibeam Avenues Ltd as on 11 March 2025 is ₹19.4.

What is the High / Low of Infibeam Avenues Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Infibeam Avenues Ltd stocks is ₹40.1/17.3.

What is the Stock P/E of Infibeam Avenues Ltd?

The Stock P/E of Infibeam Avenues Ltd is 24.1.

What is the Book Value of Infibeam Avenues Ltd?

The Book Value of Infibeam Avenues Ltd is 12.9.

What is the Dividend Yield of Infibeam Avenues Ltd?

The Dividend Yield of Infibeam Avenues Ltd is 0.26 %.

What is the ROCE of Infibeam Avenues Ltd?

The ROCE of Infibeam Avenues Ltd is 6.27 %.

What is the ROE of Infibeam Avenues Ltd?

The ROE of Infibeam Avenues Ltd is 4.71 %.

What is the Face Value of Infibeam Avenues Ltd?

The Face Value of Infibeam Avenues Ltd is 1.00.